| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/09/2004 | CN1152680C Pharmaceutical composition containing liphase inhibitors and chitosan |
| 06/08/2004 | US6747056 K99-5041 substance and production thereof |
| 06/08/2004 | US6747049 Oxazole derivatives |
| 06/08/2004 | US6747042 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 06/08/2004 | US6747031 N-heterocyclic derivatives as NOS inhibitors |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
| 06/08/2004 | US6747015 Low molecular weight polymannuronate |
| 06/08/2004 | US6747006 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 06/08/2004 | US6746675 Hypoglycemic effects and anti-tumor activity |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2262884C Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/03/2004 | WO2004046732A1 Methods for screening compounds modulating cholesterol flux and uses thereof |
| 06/03/2004 | WO2004046355A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | WO2004046148A1 Novel xanthin derivatives, production and use thereof as medicaments |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004046139A1 Benzofuran derivates, process for their preparation and intermediates thereof |
| 06/03/2004 | WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | WO2004046110A1 Antagonist to melanin-concentrating hormone receptor |
| 06/03/2004 | WO2004046107A1 Indole derivatives as somatostatin agonists or antagonists |
| 06/03/2004 | WO2004046106A1 Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045632A1 Peroxisome proliferator-activated recetor ligand |
| 06/03/2004 | WO2004045614A1 Quinoline derivatives as glucokinase ligands |
| 06/03/2004 | WO2004045605A1 Use of flavonoid for the treatment of overweight and the reduction of the mammalian appetite |
| 06/03/2004 | WO2004045604A1 Combination of flavonoid and procyanidin for the reduction of the mammalian appetite |
| 06/03/2004 | WO2004045518A2 Open chain prolyl urea-related modulators of androgen receptor function |
| 06/03/2004 | WO2004045312A1 Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material |
| 06/03/2004 | WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity |
| 06/03/2004 | WO2004002513A3 Proteins involved in the regulation of energy homeostasis |
| 06/03/2004 | WO2003103697A3 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
| 06/03/2004 | WO2003099194A3 Pharmaceutical combination of pde5 inhibitors with ace inhibitors |
| 06/03/2004 | WO2003088761A3 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003004039A3 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 06/03/2004 | WO2002070457A8 Inhibitor of monoamine uptake |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106825 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106675 class of compounds generally called the "statins" for use in stimulating bone formation and method to identify compounds useful in this regard by assessing their ability to inhibit enzymes in the pathway of isoprenoid synthesis |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106643 e.g., (1S,2R,3R,5R)-3-(3,4-Dichlorophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid ethyl ester; |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106632 5-(4-{2-'(6-methoxy-pyrimidin-4-yl)methyl-amino)-ethoxy}-benzyl)-thiazolidin-2,4-dione sodium salt |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106583 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 06/03/2004 | US20040106576 Derivatives of venlafaxine and methods of preparing and using the same |
| 06/03/2004 | US20040106574 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
| 06/03/2004 | US20040106538 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
| 06/03/2004 | US20040105908 is excellent in safety and mineral absorption enhancing effects and is capable of alleviating mineral deficiency |
| 06/03/2004 | US20040105900 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 06/03/2004 | US20040105896 Metal compunds, mixed or sulphated, as phosphate binders |
| 06/03/2004 | US20040105838 Orlistat compositions |
| 06/03/2004 | DE10254304A1 Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel New xanthine derivatives, their preparation and their use as medicaments |
| 06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | CA2506735A1 Indole derivatives as somatostatin agonists or antagonists |
| 06/03/2004 | CA2506720A1 New xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/03/2004 | CA2506331A1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2502068A1 Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424330A1 Activator for peroxisome proliferator-responsive receptor delta |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424076A1 Use of green coffee extract as mineral absorption enhancer |
| 06/02/2004 | EP1424075A2 Acid and bile-resistant lactobacillus isolates having the ability to lower and addimilate cholesterol |
| 06/02/2004 | EP1424074A1 Nutritional compositions for controlling blood glucose level |
| 06/02/2004 | EP1424070A1 Combination of a PPAR alpha agonist and metformin for decreasing the serum triglycerides |
| 06/02/2004 | EP1423708A1 Compositions and methods for aa4rp assay |
| 06/02/2004 | EP1423707A1 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423410A2 Peptides having a c-terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423388A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 06/02/2004 | EP1423382A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423370A1 Fxr nr1h4 nuclear receptor binding compounds |